Related Experiment Video
Updated: Aug 15, 2026
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Neonatal brain injury
1Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Insights
New research highlights chorioamnionitis as a key cause of neonatal brain injury. While new diagnostic and therapeutic options emerge, limited large trials create uncertainty in clinical practice for newborns.
Area of Science:
- Neonatal Medicine
- Neuroscience
- Pediatric Neurology
Background:
- Long-term outcomes for newborns are increasingly scrutinized.
- Clinical complacency is challenged by emerging data.
- Focus is shifting towards understanding neonatal brain injury etiology and management.
Purpose of the Study:
- To review clinical developments in neonatal brain injury.
- To discuss etiology, diagnostics, and therapies for preterm and term infants.
- To explore novel therapeutic strategies for clinical consideration.
Main Methods:
- Clinical review of recent advancements.
- Analysis of emerging evidence on chorioamnionitis.
- Discussion of diagnostic tools like MRI and electrophysiological monitoring.
- Evaluation of potential therapies including anti-inflammatory strategies and hormone supplementation.
Main Results:
- Chorioamnionitis is implicated as a significant factor in neonatal brain injury.
- Advanced diagnostic modalities offer new clinical insights.
- Potential novel therapies, such as anti-inflammatory agents and hormone supplementation, are identified.
- A significant lack of large-scale clinical trials hinders evidence-based therapeutic guidance.
Conclusions:
- There is a growing need for better understanding and management of neonatal brain injury.
- Emerging diagnostic and therapeutic avenues require further rigorous clinical validation.
- Uncertainty persists in clinical practice due to insufficient large trial data for guiding newborn therapies.
Abstract:
Complacency about long-term outcomes in newborns is being eroded rapidly with new information. We have examined developments in the area from an explicitly clinical approach, focusing on etiology, diagnostic modalities, and therapies. We attempt to discuss relevance from the preterm and the term perspective. Emerging evidence implicating chorioamnionitis as a significant contributor to neonatal brain injury is discussed. Therapeutic modalities such as magnetic resonance imaging and electrophysiological monitoring offer some potentially new tools for the clinician. An exploding series of basic advances suggest several potentially new strands of therapy. We discuss two that deserve further clinical exploration, namely anti-inflammatory strategies and thread hormone supplementation. In the arena of therapy, however, the paucity of large trials from which to guide therapies is a predominant theme, leaving a large reservoir of uncertainty for the clinician.
